A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma

Blood Cancer Journal, Published online: 12 January 2023; doi:10.1038/s41408-022-00768-5A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
Source: Blood Cancer Journal - Category: Hematology Authors: Source Type: research